People who treat GLP-1 therapy as a window of opportunity, using the appetite suppression to build better habits rather than just eating less of the same foods, are the ones who maintain their results when the medication dose decreases or stops
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Of the total, 43% (n=110) had IBS unspecified, 30% (n=77) had IBS constipation-predominant (IBD-C), 18% (n=46) had IBS diarrhea-predominant (IBS-D), and 9% (n=23) had IBS mixed subtype (IBS-M)
Routes of Administration Subcutaneous injection (community protocol): Community sources describe the abdomen, love handles, and thighs areas with subcutaneous fat as the typical injection sites, at a volume of approximately 0.1 mL using a 29-31 gauge insulin syringe
Sometimes having a balanced diet isnt enough, and you may require a vitamin supplement to enhance your regular nutrition intake